Skip to main content
Sun Pharma sails through Q1, but the stock may be outpacing profit growth - Livemint 02-Aug-2020
Sun Pharma sails through Q1, but the stock may be outpacing profit growth - Livemint
Sun Pharma’s active pharma ingredients (API) segment is proving resilient, with growth of about 20% y-o-y. Even so, the contribution of the API business for captive consumption is rising
More...